Model N Completes Acquisition of Revitas

January 6, 2017

Model N, Inc. (NYSE: MODN), a provider of cloud-based revenue management solutions to life sciences, technology and manufacturing companies, completed its acquisition of Revitas, Inc., a provider of life sciences revenue management software. Through this transaction, Model N now provides life sciences companies with a broader portfolio of best-in-class solutions and expanded options to leverage cloud computing to transform the management of revenue into a strategic, end-to-end process that drives growth and maximizes revenue.

“We are excited to welcome the Revitas customers, partners and employees to the Model N family,” said Zack Rinat, founder, executive chairman and CEO of Model N. “Together we will deliver increased value to our joint customers by delivering innovative revenue management solutions in the cloud.”

Model N’s acquisition of Revitas unites more than 40 years of combined revenue management experience, more than 80 life sciences customers and a presence in 10 major locations around the world. The acquisition will enable Model N to accelerate innovation across a broad set of applications to the benefit of the life sciences industry at this critical moment when revenue management is becoming a strategic imperative, one in which the industry is experiencing unprecedented and evolving global regulation, increasing price transparency, a transition from traditional consumption-based pricing to new outcome-based models and the need to acquire and divest in an M&A-centric industry.

“Today is a major milestone in the history of Model N as we increase the value we can deliver to both customers and shareholders. We expect to drive top line growth, complete the transition of our business model to 100 percent recurring revenues and accelerate our path toward profitability and cash flow generation,” said Rinat.

JMP Securities served as exclusive financial advisor to Model N and Robert W. Baird & Co. served as financial advisor to Revitas on the transaction. Durham Capital Corporation advised on the debt financing.

About Model N

Model N is a leader in revenue management solutions. Driving mission-critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and Fairchild. For more information, visit Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.